Your TSH Is "Slightly High." Here Is What the Best Trial Found.

August 4, 2026 · Last reviewed August 8, 2026

Written and reviewed by Rev. Dr. LaVeena B. Archers, PhD
Doctor of Natural Medicine · Board-certified in Holistic Functional Medicine and Functional Nutrition
Educational content only. Not medical advice, and never a substitute for your own care. Scope of practice.

In the largest placebo-controlled trial of treating a mildly raised TSH, the drug lowered the number and changed nothing anyone could feel. Across 737 adults aged sixty-five and over, average TSH fell from 6.40 to 3.63 on levothyroxine, and at one year there was no difference from placebo in hypothyroid symptoms or in tiredness ^[1]. Those participants averaged seventy-four years of age, which makes it a high-quality answer about older adults and a very limited one about a woman in her forties, because women in their forties were not in it ^[1].

Few results start more arguments than a TSH that is a little bit high while everything else looks fine.

One camp says it is nothing, come back in a year. The other says it is the missing explanation for your exhaustion, your weight, your hair and your mood, and that you should be treated now. Both speak with great confidence.

The best evidence supports neither of them comfortably, and the honest answer is more useful than either.

What is subclinical hypothyroidism?

Subclinical hypothyroidism means a raised TSH with a free thyroxine still inside the reference range.

Notice what that definition is made of. It describes a pattern in your bloodwork. It does not describe how you feel. A woman can meet the criteria and feel perfectly well. A woman can feel dreadful and not meet them at all. That mismatch is the source of nearly every argument about it.

TSH is also a signal rather than a supply. It is the message the pituitary sends asking the thyroid for more hormone, so a rising TSH means the system is working harder to keep output where it should be. Whether that extra effort matters to how you feel is exactly the question.

What did the TRUST trial find?

The TRUST trial is the largest and best designed attempt, and it was built to give a clean answer: randomized, double blind, placebo controlled ^[1].

Researchers enrolled 737 adults aged sixty-five and over with persistent subclinical hypothyroidism, meaning a TSH between 4.60 and 19.99 with free thyroxine still in range. Half received levothyroxine, starting at 50 micrograms daily (lower for smaller patients and those with heart disease) and adjusted to their TSH. Half received placebo, with mock dose adjustments so that neither they nor their doctors could tell who was getting what ^[1].

The drug did its biochemical job. Average TSH fell from 6.40 at the start to 3.63 in the treated group, against 5.48 on placebo ^[1].

Then they measured whether anyone felt better.

They did not. At one year there was no difference between the groups in the hypothyroid symptoms score, a between-group difference of 0.0, and none in the tiredness score either, at 0.4. For context, the researchers had decided in advance that a nine point difference would be the smallest change that mattered to a patient. Nothing came close. No benefit appeared on the secondary measures either ^[1].

Why that result is uncomfortable for both sides

The TRUST result costs both sides of the usual argument something, and I would rather say so than quietly pick the side that suits me.

It is uncomfortable for the natural health world, mine included, where a slightly raised TSH is often treated as a smoking gun and the explanation a woman has been denied. In these participants, correcting it changed nothing they could feel.

It is equally uncomfortable for anyone who reaches for the prescription pad on the strength of a number alone, because this is a well-powered trial saying the reflex does not deliver what it promises.

And it is hard for the woman herself, because it takes away a tidy answer without handing her another one. I would still rather she had it. A false explanation costs more than an open question, because it closes the search.

What the TRUST trial does not tell you

Here is where I part company with how the TRUST trial usually gets quoted.

The participants averaged seventy-four years of age ^[1]. That is a genuine, high quality answer about older adults. It is not an answer about a forty-six year old woman in perimenopause with a TSH of 5.2, because she was not in the study, and the physiology of a seventy-four year old is not hers.

You will see the trial cited flatly as proof that treating subclinical hypothyroidism does not work. That is an overreach. What it showed is that treating it did not work in the people who were studied.

The researchers themselves treated the question as still open at the other end of the age range, designing a further trial specifically in people aged eighty and over on the grounds that the existing evidence was inconclusive there ^[3]. Scientists deliberately extending a question is a reasonable sign that it has not been closed.

There is also evidence pointing the other way in a different group. In pregnancy, where thresholds are lower and stricter, women meeting the criteria scored measurably worse on quality of life measures than those who did not, with the effect appearing to run through anxiety ^[2]. Different population, different thresholds, different answer.

So the fair summary is not that it never matters. It is that it depends on who you are, and for a great many women the honest position is that we do not yet know.

What should you take from a slightly high TSH?

If your TSH is mildly raised, that number alone does not tell you whether treatment will make you feel better. In the group that has been best studied, it did not.

That makes the surrounding questions more important, not less. Has the result been repeated, since a single raised TSH can drift back on its own and TRUST deliberately studied people whose result had persisted ^[1]. What are your thyroid antibodies doing. What is the trend across years rather than the value on one morning. And what else could account for how you feel, given that fatigue in midlife has a long list of contributors and the thyroid is only one of them.

What I will not do is tell you whether to take thyroid medication or to stop taking it. That belongs with the person who prescribes for you. It depends on your history, your antibodies, your risks and your goals, and no article can hold all of that.

What I can tell you is that if someone offers you certainty in either direction on the strength of one slightly high number, they are more confident than the evidence is.

← All posts